In a recent study, researchers at Fox Chase Cancer Center demonstrated how amplification and rearrangement of a gene associated with leukemia known as MLL is directly controlled by epigenetic factors, providing needed insights into a new therapeutic opportunity.
A Fox Chase Cancer Center researcher has been awarded a $2.5 million grant from the National Institute of General Medical Sciences to investigate RNA structure and stability, work that has implications for cancer, Alzheimer’s, and other degenerative diseases and continues the Fox Chase legacy of basic research.
Around Town - Northeast Times northeasttimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northeasttimes.com Daily Mail and Mail on Sunday newspapers.
Openings may be found in consolidated genetic/epigenetic sequencing workflows, linksbetween chromatin changes and disease states, and reversible epigenetic changes.
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.